As nicely outlined in a quite recent authoritative review [42], the focus on HIFs and metabolic diseases has led to the acquisition of a number of major critical concepts that have also started to discriminate the sometimes alternative roles of HIF-1α and HIF-2α. This evidence concerns the gene EPAS1 and Other metabolic disease.